Exome sequencing for structurally normal fetuses—yields and ethical issues
Open Access
- 7 September 2022
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 31 (2) , 164-168
Abstract
The yield of chromosomal microarray analysis (CMA) is well established in structurally normal fetuses (0.4–1.4%). We aimed to determine the incremental yield of exome sequencing (ES) in this population. From February 2017 to April 2022, 1,526 fetuses were subjected to ES; 482 of them were structurally normal (31.6%). Only pathogenic and likely pathogenic (P/LP) variants, per the American College of Medical Genetics and Genomics (ACMG) classification, were reported. Additionally, ACMG secondary findings relevant to childhood were reported. Four fetuses (4/482; 0.8%) had P/LP variants indicating a moderate to severe disease in ATP7B, NR2E3, SPRED1 and FGFR3, causing Wilson disease, Enhanced S-cone syndrome, Legius and Muenke syndromes, respectively. Two fetuses had secondary findings, in RET and DSP. Our data suggest that offering only CMA for structurally normal fetuses may provide false reassurance. Prenatal ES mandates restrictive analysis and careful management combined with pre and post-test genetic counseling.Keywords
This publication has 40 references indexed in Scilit:
- Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening PanelsPLOS ONE, 2014
- Clinical Exome Sequencing for Genetic Identification of Rare Mendelian DisordersJAMA, 2014
- Clinical and Molecular Characterization of Enhanced S-Cone Syndrome in ChildrenJAMA Ophthalmology, 2014
- Exome sequence read depth methods for identifying copy number changesBriefings in Bioinformatics, 2014
- Compliant treatment with anti‐copper agents prevents clinically overt Wilson's disease in pre‐symptomatic patientsEuropean Journal of Neurology, 2013
- Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Revised 2010 Task Force Criteria With Inclusion of Non-Desmosomal Phospholamban Mutation CarriersThe American Journal of Cardiology, 2013
- “Selfish Spermatogonial Selection”: A Novel Mechanism for the Association Between Advanced Paternal Age and Neurodevelopmental DisordersAmerican Journal of Psychiatry, 2013
- Chromosomal Microarray versus Karyotyping for Prenatal DiagnosisNew England Journal of Medicine, 2012
- De novo mutations in human genetic diseaseNature Reviews Genetics, 2012
- Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfectaAmerican Journal of Medical Genetics, 1995